International Conference on Systems Engineering

Analysis Group and Pfizer Present Interim Data on COVID-19 Vaccine Safety Surveillance Program Showing No Adverse Safety Signals Among US Veterans Health Administration Patients

Retrieved on: 
Tuesday, August 30, 2022
European Medicines Agency, COVID-19, EMA, EUA, CEO, Safety, Lan Yinong, International Society for Pharmacoepidemiology, Program, Emergency Use Authorization, Analysis Group, Government, VHA, Infarction, Pfizer, US Food Sovereignty Alliance, Man, Veteran, Veterans Health Administration, International Society, COVID 19, Particle-size distribution, Acute kidney injury, Principal, Anaphylaxis, Biostatistics, Conference, FDA, Population, International Conference on Systems Engineering, Influenza, Health, Epidemiology, Industry, COVID, Pharmaceutical industry, DRS, Pharmacoepidemiology

BOSTON, Aug. 30, 2022 /PRNewswire/ -- During the International Society of Pharmacoepidemiology's annual meeting, researchers from Analysis Group (a global leader in health care consulting), the Veterans Health Administration (VHA), and Pfizer presented interim data from 1,448,043 US veterans who were among the first to receive the Pfizer-BioNTech COVID-19 vaccine, between December 11, 2020, and September 24, 2021. In this interim analysis, no adverse safety signals were found among the study population, who overwhelmingly completed the primary series of two doses (96%). With study completion planned for December 2023, the safety of the vaccine will continue to be evaluated by study investigators.

Key Points: 
  • In this interim analysis, no adverse safety signals were found among the study population, who overwhelmingly completed the primary series of two doses (96%).
  • With study completion planned for December 2023, the safety of the vaccine will continue to be evaluated by study investigators.
  • Analysis Group researchers designed the study protocol and collaborated with the VHA to identify near real-time safety signals among vaccinated individuals over the course of 30 months.
  • Forty-six pre-specified safety events of interest were included in the vaccine safety surveillance program, including cerebrovascular non-hemorrhagic stroke, acute myocardial infarction, chilblain-like lesions, anaphylaxis, and acute kidney injury.

Convergint and its Colleagues Donate More Than $60,000 to Charity During 2022 InterNational Conference

Retrieved on: 
Tuesday, May 3, 2022
Philanthropy, Security, Technology, Other Philanthropy, Fund Raising, Foundation, SDM, Social responsibility, International Conference on Systems Engineering, International, Conference, CEO, Technology, Pharmaceutical industry

Of these donations, $58,000 was donated by colleagues and partners, and an additional $5,000 was donated by Convergint.

Key Points: 
  • Of these donations, $58,000 was donated by colleagues and partners, and an additional $5,000 was donated by Convergint.
  • Giving back comes naturally to Convergints colleaguesand the funds donated to our foundations this year, over just four days, are nothing short of impressive, said Ken Lochiatto, CEO of Convergint.
  • Charitable initiatives at Convergints InterNational conference included:
    The Convergint Cares Foundation: the Convergint Cares Foundations mission is to provide educational financial assistance to the families of US-based Convergint colleagues and further Convergints global social responsibility efforts supporting not-for-profit entities throughout underserved communities.
  • The Nimsdai Foundation : this foundation was founded by 2022 Convergint InterNational guest speaker Nimsdai Purja as a means of giving back to the mountain communities of his homeland.

Pivotal Trial Results of the iLet® Bionic Pancreas To Be Presented at ATTD

Retrieved on: 
Monday, April 25, 2022
ATTD, T1D, Glucagon, Federal, Population, Human, Twitter, Boston University, Associate, YouTube, GLOBE, Treatment, National, Sale, Central European Summer Time, LinkedIn, Conference, Technology, Public relations, Insulin, ADA, Randomized controlled trial, Meal, Bionics, Safety, Ilet, Instagram, IO, Standard of care, Harvard Medical School, Quality of life, International Conference on Systems Engineering, CEST, Glycated hemoglobin, Time, Interim, Honda advanced technology, Pharmaceutical industry, Medical device, Medicine, CONCORD, Diabetes

The iLet Bionic Pancreas is a pocket-sized, wearable device that is designed to autonomously determine and deliver insulin doses to control blood glucose levels in people with diabetes.

Key Points: 
  • The iLet Bionic Pancreas is a pocket-sized, wearable device that is designed to autonomously determine and deliver insulin doses to control blood glucose levels in people with diabetes.
  • The Insulin-Only Bionic Pancreas Pivotal Trial population was more diverse and representative of the United States type 1 diabetes community than any previous pivotal trial of an automated insulin delivery system.
  • Beta Bionics is a clinical stage medical technology company focused on the design, development, and commercialization of its iLet Bionic Pancreas in both the insulin dosing (the iLet) and bihormonal (iLet Duo) configurations.
  • Caution: The iLet Bionic Pancreas is an investigational device limited by Federal (or United States) law to investigational use.

Convergint Announces 16th Annual International Conference, Celebrating Colleagues and Fostering Collaboration With Global Partners

Retrieved on: 
Monday, February 28, 2022
Security, Consumer Electronics, Technology, Other Technology, Audio, Video, Hardware, Conference, Achievement, SDM, International Conference on Systems Engineering, Industry, Gaylord Texan Resort Hotel & Convention Center, Convention center, CEO, Leadership, Risk management

Convergint , a global leader in service-based systems integration, today announced that its annual Convergint InterNational Conference will take place March 6-9, 2022 at the Gaylord Texan Resort & Convention Center in Grapevine, Texas.

Key Points: 
  • Convergint , a global leader in service-based systems integration, today announced that its annual Convergint InterNational Conference will take place March 6-9, 2022 at the Gaylord Texan Resort & Convention Center in Grapevine, Texas.
  • The 2022 Convergint InterNational Conference will include a keynote from Nimsdai Purja focused on leadership and teamwork, business updates from Convergint leaders, and colleague recognition, along with opportunities for professional development.
  • Our dedication to fostering a collaborative and people-first environment, upskilling our colleagues, and celebrating their achievements is an annual highlight for the entire Convergint community.
  • As recognition is a pillar of Convergint InterNational conferences, Convergint colleagues will be toasted at an annual awards dinner, recognizing standout achievement and success among colleagues, and celebrating global growth across the organization.

Stronghold Data Named MSP of the Year by ChannelFutures and Channel Partners MSP 501

Retrieved on: 
Wednesday, December 1, 2021
Conference, Industry, Partnership, Marketing, Health, Market share, Administration, MSP, Project engineering, International Conference on Systems Engineering, Video game, Renewable energy

LAS VEGAS, Dec. 1, 2021 /PRNewswire/ -- Stronghold Data, a New Charter Technologies Company, has been named the MSP of the Year by the prestigious Channel Partners and Channel Futures MSP 501 at the MSP Summit held November 1-2 in Las Vegas as part of the Channel Partners Conference & Expo.

Key Points: 
  • LAS VEGAS, Dec. 1, 2021 /PRNewswire/ -- Stronghold Data, a New Charter Technologies Company, has been named the MSP of the Year by the prestigious Channel Partners and Channel Futures MSP 501 at the MSP Summit held November 1-2 in Las Vegas as part of the Channel Partners Conference & Expo.
  • Stronghold Data has been selected as the industry-leading MSP by the research team and editors of the Channel Futures company.
  • Only MSPs that were included on The Channel Futures MSP 501 prestigious and definitive listing were eligible for this honor.
  • "Channel Futures has graciously awarded their MSP of the Year award to Stronghold Data.

Registration for ASC22 Student Supercomputer Challenge Now Open

Retrieved on: 
Tuesday, November 16, 2021
Software, Networks, Hardware, Electronic Design Automation, Consumer Electronics, Technology, University, Education, Model, Novel coronavirus, Engineering, MPAS, International Conference on Systems Engineering, SC21, HPL, HPCG, ASC, High, Top7, AI, Conference, CST, Southern University of Science and Technology, AWS, Cloud computing, High Performance Computing Modernization Program, HPC, Video game

Registration for the ASC Student Supercomputer Challenge 2022 (ASC22) is underway.

Key Points: 
  • Registration for the ASC Student Supercomputer Challenge 2022 (ASC22) is underway.
  • The session will be hosted by Vangel Bojaxhi, Executive Director of ASC, who will introduce the competition system, schedule, tasks, etc.
  • The ASC Student Supercomputer Challenge is the worlds largest student supercomputing competition.
  • The ASC Student Supercomputer Challenge is sponsored and organized by Asia Supercomputer Community and supported by Asian, European, and American experts and institutions.